ROSS\JOHNSON & Associates »

Halozyme Therapeutics shares owned by ROSS\JOHNSON & Associates

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by ROSS\JOHNSON & Associates from 13F filings

Historical chart of ROSS\JOHNSON & Associates investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by ROSS\JOHNSON & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by ROSS\JOHNSON & Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $269 4 67.25

More positions owned by ROSS\JOHNSON & Associates

Graco Common / Ordinary Stock (GGG)
SSgA Funds Management Exchange Traded Fund (SPY)
Tesla Common / Ordinary Stock (TSLA)
Ishares/usa Exchange Traded Fund (MUB)
Ishares Exchange Traded Fund (IVV)
SEI Exchange Traded Funds Exchange Traded Fund (SEEM)
Benchmark Electronics Common / Ordinary Stock (BHE)
SEI Exchange Traded Funds Exchange Traded Fund (SEIS)
Wells Fargo & Co Common / Ordinary Stock (WFC)
Bitwise Bitcoin Etf Exchange Traded Fund (BITB)
ARK 21 Shares/USA Exchange Traded Fund (ARKB)
NVIDIA Corp Common / Ordinary Stock (NVDA)
Amgen Common / Ordinary Stock (AMGN)
Cisco Systems Common / Ordinary Stock (CSCO)
UnitedHealth Group Common / Ordinary Stock (UNH)

View all positions for ROSS\JOHNSON & Associates

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics